Can Fite Biopharma Ltd ADR
Quarterly Financials
| Values in thousands | 2024-06-30 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $158 | $158 | $196 | $196 |
Gross Profit | 158 | 158 | 196 | 196 |
EBITDA | -2,046 | -2,046 | -1,861 | -1,784 |
EBIT | -2,047 | -2,047 | -1,865 | -1,784 |
Net Income | -1,978 | -1,978 | -1,762 | -1,670 |
Net Change In Cash | 158 | 158 | 196 | 196 |
Free Cash Flow | -2,019 | -2,019 | ||
Cash | 4,719 | 4,719 | 3,383 | 3,458 |
Basic Shares | 1,821,304 | 1,821,304 | 1,225,171 | 3,929 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $743 | $810 | $853 | $763 |
Gross Profit | 743 | 810 | 853 | 763 |
EBITDA | -8,180 | -10,082 | -12,828 | -14,127 |
EBIT | -8,195 | -10,096 | -12,842 | -14,138 |
Net Income | -7,634 | -10,236 | -12,595 | -14,443 |
Net Change In Cash | 743 | 810 | 853 | 763 |
Free Cash Flow | -8,442 | -10,810 | -9,869 | -12,089 |
Cash | 4,278 | 2,978 | 4,390 | 8,268 |
Basic Shares | 1,278,333 | 815,746 | 553,079 | 358,411 |
Earnings Calls
| Quarter | EPS |
|---|---|
2023-12-31 | -$1.49 |
2023-09-30 | -$0.44 |
2023-06-30 | -$0.42 |
2023-03-31 | -$0.65 |
